Office of the Secretary August 9, 2019 – Federal Register Recent Federal Regulation Documents

Sugar Charged Against the FY 2019 Raw Sugar Tariff-Rate Quota May be Entered Until October 15, 2019
Document Number: 2019-17130
Type: Notice
Date: 2019-08-09
Agency: Department of Agriculture, Office of the Secretary
The U.S. Department of Agriculture today announced that sugar charged against the FY 2019 raw sugar tariff-rate quota (TRQ) will be permitted to enter U.S. Customs territory until October 15, 2019, two weeks later than usual, to provide more opportunity for supplying countries to fill their import quotas. Additional U.S. Note 5(a)(iv) of Chapter 17 of the U.S. Harmonized Tariff Schedule provides: ``(iv) Sugar entering the United States during a quota period established under this note may be charged to the previous or subsequent quota period with the written approval of the Secretary.'' Pursuant to the Congressional Review Act, the Office of Information and Regulatory Affairs designated this rule as not a major rule.
Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Application To Withdraw Tribal Funds From Trust Status
Document Number: 2019-17110
Type: Notice
Date: 2019-08-09
Agency: Department of the Interior, Office of the Secretary
In accordance with the Paperwork Reduction Act of 1995, we, the Office of the Special Trustee for American Indians (OST) are proposing to renew an information collection.
Agency Information Collection Activities; Submission for OMB Review; Comment Request; Benefits Rights and Experience Report
Document Number: 2019-17085
Type: Notice
Date: 2019-08-09
Agency: Department of Labor, Office of the Secretary
The Department of Labor (DOL) is submitting the Employment and Training Administration (ETA) sponsored information collection request (ICR) titled, ``Benefits Rights and Experience Report'' to the Office of Management and Budget (OMB) for review and approval for continued use, without change, in accordance with the Paperwork Reduction Act of 1995 (PRA). Public comments on the ICR are invited.
Medicare Program: Proposed Changes to Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs; Price Transparency of Hospital Standard Charges; Proposed Revisions of Organ Procurement Organizations Conditions of Coverage; Proposed Prior Authorization Process and Requirements for Certain Covered Outpatient Department Services; Potential Changes to the Laboratory Date of Service Policy; Proposed Changes to Grandfathered Children's Hospitals-Within-Hospitals
Document Number: 2019-16107
Type: Proposed Rule
Date: 2019-08-09
Agency: Centers for Medicare & Medicaid Services, Department of Health and Human Services, Office of the Secretary
This proposed rule proposes revisions to the Medicare hospital outpatient prospective payment system (OPPS) and the Medicare ambulatory surgical center (ASC) payment system for CY 2020 based on our continuing experience with these systems. In this proposed rule, we describe the proposed changes to the amounts and factors used to determine the payment rates for Medicare services paid under the OPPS and those paid under the ASC payment system. In addition, this proposed rule would update and refine the requirements for the Hospital Outpatient Quality Reporting (OQR) Program and the ASC Quality Reporting (ASCQR) Program. In addition, in this proposed rule, we are proposing to establish requirements for all hospitals in the United States for making hospital standard charges available to the public; establish a process and requirements for prior authorization for certain covered outpatient department services; revise the conditions for coverage of organ procurement organizations; and revise the regulations to allow grandfathered children's hospitals-within- hospitals to increase the number of beds without resulting in the loss of grandfathered status. We also solicit comments on potential revisions to the laboratory date of service policy under the Clinical Laboratory Fee Schedule. Finally, we solicit comments on an appropriate remedy in litigation involving our OPPS payment policy for 340B- acquired drugs, which would inform future rulemaking in the event of an adverse decision on appeal in that litigation.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.